New Delhi, July 16: The Delhi High Court on Friday said it would be a disaster if COVID-19 vaccines are administered, especially to children, without clinical trials and asked the Centre that it should take steps to quickly vaccinate kids of below 18 years of age once the trials are over as the whole nation is waiting for it.
The court was informed by the Centre that clinical trials for the vaccines for children under 18 years of age are going on and on the verge of completion and that a policy will be formed by the government and children will be vaccinated when experts give permission.
Let the trials be done, otherwise it would be a disaster if vaccines are administered without trials that too in case of children, a bench of Chief Justice D N Patel and Justice Jyoti Singh observed.
Once trials are over, you quickly apply to children. The whole country is waiting, it added and listed the matter for further hearing on September 6.
The high court was hearing a PIL filed on behalf of a minor which sought directions for the immediate vaccination of those in the 12-17 age group on the ground that there were fears a likely third wave of COVID-19 could affect them more.
Additional Solicitor General Chetan Sharma, representing the Centre, said pharmaceutical company Zydus Cadila which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 years of age and subject to the statutory permission, the same may be available in near future for children of the age group of 12 to 18 years of age.
The Centre, in the affidavit filed through standing counsel Anurag Ahluwalia, said vaccination is the top most priority of the government and all efforts are being made to achieve an objective of 100 per cent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration.
It said from May 1, onwards under the new liberalised pricing and accelerated national COVID vaccination strategy, all citizens above the age of 18 years including parents of children who are residing in Delhi are already eligible for the vaccination.
The Centre said on May 12, Drug Controller General of India has permitted Bharat Biotech to conduct clinical trials on the healthy volunteers between 2 to 18 years of age for its vaccine Covaxin.
Senior advocate Kailash Vasudev, representing the petitioner, said vaccines are being administered to children of the age group of 8 to 18 years in various countries and the court may ask the authorities to conclude the process in a time bound manner.
To this, the bench said the government was saying that trials are going on and there cannot be a time bound schedule for a research.
They are only asking for a breathing time. Everybody is working, the bench said, adding that looking into the stand taken by the Centre that the trials are going on and are at the verge of completion, list the petition on September 6. (PTI)